SCHEMBL4753305

SCHEMBL4753305

Cc1nn(-c2ccccc2)c(C)c1CN1CCN(C(=O)CCCc2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
AR P10275 1/20 0.51
SMO Q99835 3/20 0.51
MAPT P10636 2/20 0.50
SIGMAR1 Q99720 2/20 0.49
TSHR P16473 2/20 0.49
HTR7 P34969 2/20 0.47
RECQL P46063 1/20 0.46
CACNA1F O60840 1/20 0.45
DRD1 P21728 1/20 0.45
DRD4 P21917 1/20 0.45
DRD5 P21918 1/20 0.45
HRH2 P25021 1/20 0.45
ADRA1D P25100 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA1A P35348 1/20 0.45
HRH1 P35367 1/20 0.45
ADRA1B P35368 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21384787 0.76 MAPT (0.49) NPC1RAB9AMAPTTSHRHTR7
SCHEMBL5338313 0.74 SMO (0.59) NPC1RAB9ASMOTSHRRECQL
SCHEMBL8235059 0.73 MAPT (0.79) NPC1RAB9AARMAPTHTR7
SCHEMBL4751033 0.71 SMO (0.59) SMOMAPTTSHRDRD3ALDH1A1
SCHEMBL13020231 0.71 OPRM1 (0.47) NPC1RAB9ASMOTSHRRECQL
SCHEMBL7730871 0.71 NPC1 (0.68) NPC1RAB9AARMAPTSIGMAR1
SCHEMBL19981211 0.71 MAPT (0.54) MAPTHTTMAPK1
SCHEMBL4754231 0.70 BLM (0.48) NPC1RAB9ASMOMAPTOPRM1
SCHEMBL9819732 0.70 TSHR (0.71) NPC1MAPTSIGMAR1TSHRHTR7
SCHEMBL20306240 0.70 AR (0.65) NPC1RAB9AARMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed